Biocortech - Product Pipeline Analysis - New Market Research Report
Biocortech is a biotechnology company, based in France. The company operates through the development of biological tests for the patients with psychiatric disorders and for monitoring their treatments. It is developed in a vitro cell line assay to assess candidate drug's risk to induce severe psychiatric side effects. The company also develops novel diagnostics from receptor editing technology platform for psychiatric disorders. Its product portfolio includes, DIADEP, biological test predictive of depression and EDITOX, drug screening assay predictive of neuropsychiatric...
View full press release